Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a by Kim, Kun-Yong et al.
ARTICLE
Uhrf1 regulates active transcriptional marks at
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Embryonic stem cells (ESCs) maintain pluripotency through unique epigenetic states. When
ESCs commit to a specific lineage, epigenetic changes in histones and DNA accompany the
transition to specialized cell types. Investigating how epigenetic regulation controls lineage
specification is critical in order to generate the required cell types for clinical applications.
Uhrf1 is a widely known hemi-methylated DNA-binding protein, playing a role in DNA
methylation through the recruitment of Dnmt1 and in heterochromatin formation alongside
G9a, Trim28, and HDACs. Although Uhrf1 is not essential in ESC self-renewal, it remains
elusive how Uhrf1 regulates cell specification. Here we report that Uhrf1 forms a complex with
the active trithorax group, the Setd1a/COMPASS complex, to maintain bivalent histone
marks, particularly those associated with neuroectoderm and mesoderm specification.
Overall, our data demonstrate that Uhrf1 safeguards proper differentiation via bivalent his-
tone modifications.
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Uhrf1 (Ubiquitin-like, with PHD and RING finger domains1, also known as NP95 or ICBP90) is a multi-domainnuclear protein that faithfully regulates epigenetic mod-
ifications through two mechanisms: (i) by recognition of histone
marks through subsequent interactions with chromatin modify-
ing proteins and (ii) DNA methylation maintenance1. Uhrf1 is
essential in early embryogenesis2–4. Although Uhrf1 knock-out
(KO) mouse embryonic stem cells (ESCs) are viable and able to
self-renew, they display delayed cell cycle progression, a loss of
DNA methylation, altered chromatin structure, and enhanced
transcription of repetitive elements2,4. Uhrf1 is also highly
expressed in neural stem cells (NSCs). Interestingly, loss of
Uhrf1 in NSCs leads to the activation of retroviral elements,
similar to that observed in Uhrf1 KO ESCs5. Recent studies
showed that a reduction of Uhrf1 expression via Pramel7
(PRAME-like 7) is important in the conversion of primed ESCs
to a naive state6,7.
One of the major functions of Uhrf1 is the inheritance of DNA
methylation during DNA replication. Uhrf1 binds to hemi-
methylated DNA via its Set- and RING-Associated (SRA)
domain, which facilitates the loading of DNA methyltransferase 1
(Dnmt1) onto the newly synthesized DNA strand during cell
division8. The plant homeo domain (PHD) and tandem Tudor
domain (TTD) domains of Uhrf1 simultaneously recognize tri-
methylated H3 at lysine 9 (H3K9me3), which could potentially
contribute to the interplay between histone modification and
DNA methylation, and the localization of H3K9me3 to peri-
centric heterochromatin9–11. Uhrf1 also contains a really inter-
esting new gene (RING) domain that ubiquitylates histone H3 at
lysine 23 (H3K23ub) and is essential for the recruitment of
Dnmt1 for the maintenance of DNA methylation12. Recent dis-
coveries have demonstrated Uhrf1’s bipartite role as a DNA
damage sensor and nuclease scaffold in DNA repair, as well as the
importance of its SRA domain13–15. Although the biochemical
function of Uhrf1 in DNA methylation and heterochromatin
formation has been extensively investigated, its biological func-
tion in ESCs has yet to be explored.
Bivalent histone marks, represented by H3K4me3 and
H3K27me3, are unique features of promoters associated with
development and differentiation in ESCs16. When ESCs differ-
entiate into a given lineage, active histone marks are maintained
in genes that are expressed in that specific lineage, while the
repressive histone marks in those genes are concomitantly
removed16. The polycomb repressive complex 2 (PRC2) proteins
mediate H3K27me3 modification to regulate gene repression17,18.
In contrast, H3K4 methylation is catalyzed by the Set1 complex
proteins. Metazoans have three subsets of this complex: the Set1/
COMPASS, trithorax (Trx), and trithorax-related (Trr). These
complexes share the same core protein components, but differ in
their catalytic subunits. The Set1/COMPASS complex has Setd1a
or Setd1b as its catalytic subunit, while Trx has myeloid/lymphoid
or mixed-lineage leukemia 1 (MLL1) or MLL2, and Trr has MLL3
or MLL419. Set/MLL core subunits, such as WD repeat-
containing protein 5 (Wdr5), Ash2l (Ash2-like), and
retinoblastoma-binding protein 5 (Rbbp5), are required for full
histone methyltransferases (HMT) activity of the Set complex,
while Rbbp5 and Ash2l heterodimer participates in the HMT
activity of MLL1 complex20–23. In spite of overwhelming evidence
that Uhrf1 regulates repressive histone marks, it is still unclear
whether Uhrf1 is involved in the regulation of active chromatin
marks.
Here, we investigate the function of Uhrf1 in its regulation of
pluripotency and differentiation of ESCs. Surprisingly, our data
show that Uhrf1 plays a critical role in lineage specification by
controlling bivalent histone modifications. Its deletion in ESCs
disrupts not only the repressive mark H3K27me3, but also the
active histone mark H3K4me3 on bivalent loci, ultimately causing
defects in differentiation. Furthermore, biochemical analysis
demonstrates that Uhrf1 interacts with the Setd1a/COMPASS
complex and positively regulates H3K4me3 modifications. Our
findings reveal an essential function of Uhrf1 as a stabilizer of the
epigenome by promoting H3K4me3 modifications necessary for
faithful differentiation and the maintenance of bivalent histone
modifications for pluripotency.
Results
Uhrf1 deficiency disrupts bivalent histone marks in ESCs. We
first performed chromatin-immunoprecipitation with high-
throughput sequencing (ChIP-seq) to identify global targets of
Uhrf1. 2784 Uhrf1-enriched regions (10.2%) were identified
around promoters or gene bodies, while 10,860 were located in
the intergenic regions (89.8%) (Fig.1a). Comparative analysis with
ChIP-seq for histone modifications showed that the genome-wide
distribution of Uhrf1 is most significantly correlated with that
of H3K9me3 marks (Pearson correlation= 0.928, p < 2.2e−16,
Supplementary Fig. 1a), consistent with previous findings
that Uhrf1 directly interacts with H3K9me324. Interestingly,
Uhrf1 distribution was also highly correlated with H3K4me3
and H3K27me3 mark distribution (correlation= 0.582 and
0.747, respectively) (Supplementary Fig. 1a). In contrast, 5-
hydroxymethyl-cytosine (5hmC) or methyl-cytosine (5mC) did
not appear to correlate with Uhrf1-binding patterns (correlation
=−0.113 and −0.149, respectively) (Supplementary Fig. 1a)25. In
addition, comparative analysis of transcriptome profiles of Uhrf1
KO and Dnmt1 KO ESCs showed that only 12.3% of the up-
regulated genes and 4.4% of the down-regulated genes overlapped
(Fig. 1b)26. Pluripotent-related genes (e.g. Prdm14, Rex1 and
Lefty1) were dysregulated uniquely in Dnmt1 KO ESCs, while
Uhrf1 KO cells exhibited dysregulation in several developmental
genes (Hand1 and Sox15), and genes exclusively expressed at
the early embryonic stage (e.g. Klf2 and Zscan4b) (Fig. 1b).
Gene ontology (GO) analysis also revealed that genes involved in
protein ubiquitination and DNA repair, the known functions
of Uhrf1, were uniquely down regulated in Uhrf1 KO ESCs14,25.
These results suggest that Uhrf1 chromatin occupancy is highly
associated with histone modification rather than DNA methyla-
tion, despite the fact that Uhrf1 is involved in the recruitment of
Dnmt1 to facilitate DNA methylation through H3K9me3
binding10.
To determine Uhrf1’s contribution to chromatin organization,
we compared various histone modifications (H3K4me3,
H3K27me3, and H3K9me3) between wild type (WT) and Uhrf1
KO ESCs. We found that Uhrf1 deficiency disrupted H3K4me3,
H3K27me3, and H3K9me3 modifications (Supplementary
Fig. 1b). Notably, disruption of H3K4me3 and H3K27me3
preferentially occurred at transcription start sites (TSSs) (p <
2.2e−16, “E” in Fig. 1c), whereas H3K9me3 disruptions occurred
predominantly in intergenic regions (Supplementary Fig. 1c), L1
and LTR class retrotransposons (Supplementary Fig. 1d). Our
results suggest that Uhrf1 not only localizes to heterochromatic
regions, but also to specific euchromatic regions for transcrip-
tional regulation of genes through regulation of H3K4me3 and
H3K27me3 modifications.
Using WT and Uhrf1 KO ESCs, we next classified promoters
into four distinct states, either active, repressive, bivalent, or no
mark, indicated by the presence or absence of H3K4me3 and
H3K27me3 marks (Supplementary Fig. 1e). We observed that
while the majority of active and no-mark promoters were
retained in Uhrf1KO ESCs, half of repressive promoters
(50.4%) were switched to no-mark promoters in Uhrf1KO ESCs.
Interestingly, 55% of the bivalent marks observed in WT ESCs
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were disrupted and redistributed into either repressive (13.95%)
or active (33.57%) promoter states in Uhrf1 KO cells (Fig. 1d).
Uhrf1 was significantly enriched around bivalent and repressive
loci (p < 3.07e−2, Supplementary Fig. 1f). In addition, Uhrf1 KO
ESCs showed a significant decrease in H3K4me3 and H3K27me3
modifications at the promoters of mesodermal genes and a
decrease of H3K4me3 in ectodermal genes (p < 4.86−2 by T test,
Supplementary Fig. 1g). This was further validated using ChIP-
qPCR, against genes involved in differentiation and pluripotency.
For example, genes involved in muscle development (e.g. Msx2
and Hand2) showed a marked reduction of H3K4me3 and
H3K27me3, while neuroectoderm (e.g. Tubb3 and Nes) and
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Fig. 1 Uhrf1 deficiency disrupts bivalent histone modification. a Distribution of Uhrf1-enriched regions in gene body and intergenic regions. b Comparative
analysis of up-regulated (left) and down-regulated genes (right) between Uhrf1 and Dnmt1 KO. Representative genes and over represented GO terms for
unique and common genes are also shown. Dashed line represents 0.05 FDR cut-off. c Comparative analysis of H3K4me3, H3K27me3, and H3K9me3
change between Uhrf1-enriched (e) and Uhrf1-depleted (d) regions. Y-axis represents the difference of log2(ChIP/input) between WT and Uhrf1 KO. d
Changes of promoter classes between WT and Uhrf1 KO ESCs. e Histone modification landscape of representative genes related to pluripotency,
mesoderm/mesenchyme/muscle, and neuroectoderm development. f GSEA for stem cell functions. Statistical enrichment (−log10(FDR)) in Uhrf1 KO and
WT was shown by blue and red color, respectively
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pluripotency genes (e.g. Klf2 and Sall1) displayed a loss of
H3K4me3 (Fig. 1e and Supplementary Fig. 1h, i).
To determine whether the disruption of a bivalent state in
poised promoters by KO of Uhrf1 truly affects gene expression
levels, we compared global gene expression between WT and
Uhrf1 KO ESCs. Surprisingly, only a few hundred genes were
differentially expressed between WT and Uhrf1 KO ESCs
(Fig. 1b). Despite the observed differential modification of
H3K4me3 and H3K27me3 on the ectodermal and mesodermal
genes (Supplementary Fig. 1g), Uhrf1 deficiency in ESCs did not
significantly affect stem cell maintenance (FDR= 0.298), triline-
age developmental genes (FDR > 0.060) or trophectoderm (FDR
= 0.501) (Fig. 1f)27. Although Uhrf1-derived bivalent disruption
had little influence on trilineage-related gene expression in Uhrf1
KO ESCs, disrupted bivalent marks in Uhrf1 KO ESCs reveal a
previously undefined function of Uhrf1 as a regulator of cell
lineage specification during differentiation.
Uhrf1 is critical in mesodermal and ectodermal differentia-
tions. To address if bivalent disruption impacts ESCs differ-
entiation, we assessed embryoid body (EB) formation using WT
and Uhrf1 KO ESC lines. Uhrf1 KO EBs presented with an
irregular and inflated shape as early as day 7 when compared to
the spherical EBs derived from WT ESCs (Fig. 2a). In addition to
the gross morphological differences, Uhrf1 KO ESCs formed
contractile EBs earlier than WT ESCs. WT EBs started beating at
around day 9 and showed a gradual decrease in beating until day
21, while Uhrf1 KO EBs exhibited rhythmical beating as early as
day 5. The proportion of beating EBs in Uhrf1 KO dramatically
decreased after day 10, and the majority of EBs had ceased to beat
by day 12 (Fig. 2b). Gene expression analyses of trilineage mar-
kers showed an upregulation of the mesodermal markers Nkx2.5
and Tbx5 in the early stages of Uhrf1 KO EB formation (Fig. 2c).
In contrast, the neuroectodermal markers Sox1 and TuJ showed
down regulation in Uhrf1 KO cells, compared with WT cells. The
observed bias in differentiation of Uhrf1 KO ESCs towards
mesoderm, combined with reduced neuroectoderm potential was
further clarified by immunostaining against early lineage-specific
markers (Fig. 2d). Moreover, when Uhrf1 KO ESCs were differ-
entiated towards the neural lineage by exposure to retinoic acid
(RA), we observed a striking increase of cell death and a failure to
neuralise (Supplementary Fig. 2a). To eliminate potential clonal
variation, we derived the following mESC cell lines: JES6 derived
from Uhrf1fl/fl mouse and the Uhrf1-null mESC line (JES6-Cre)
(Supplementary Fig. 2b, c). Consistent with the already described
Uhrf1 KO cell line, JES6-Cre mESCs presented with the same
defects in both neural differentiation and expedited formation of
beating EBs (Supplementary Fig. 2d, f). These results importantly
point towards a previously unidentified role of Uhrf1 in reg-
ulating lineage specification.
To further evaluate the role of Uhrf1 in ESC differentiation
in vivo, we performed a teratoma assay by intramuscular injection
of Uhrf1 KO and WT ESCs into immune-deficient mice. We were
able to isolate teratomas derived from Uhrf1 KO ESCs that
contained representative tissues for all the three germ layers
(Fig. 2e). However, teratomas were much smaller as compared to
WT ESCs (Fig. 2f and Supplementary Fig. 2g). This highlighted
that the observed differentiation defect exerted by Uhrf1 KO is a
phenotype that occurs both in vitro and in vivo.
In order to test whether the observed differentiation defect was
a consequence of the absence of Uhrf1 and not due to
abnormalities inherent with Uhrf1 KO ESC line, we ectopically
expressed recombinant Uhrf1 in Uhrf1 KO cells. Importantly, the
introduction of Uhrf1 rescued the abnormal morphology in EBs
(Fig. 2a—lower panel), as well as premature mesodermal
differentiation, as demonstrated by the recovery of EB beating
time (Fig. 2b). Furthermore, the expression of trilineage markers,
in particular the neuroectoderm markers Sox1 and TuJ, were
rescued to WT levels (Fig. 2c). The accelerated expression of
mesodermal markers Bmp4 and Nkx2.5 at early stage of Uhrf1
KO EBs was rescued to near WT levels. Taken together, Uhrf1
regulates the expression of lineage-specific genes to achieve
correctly mediated ESC differentiation.
To gain more global insight into the role of Uhrf1 in the
regulation of differentiation, RNA-seq was performed with EBs
from both WT and Uhrf1 KO cells. We observed a large number
of genes that were differentially expressed as differentiation
progressed (Supplementary Fig. 3a). Consistent with the con-
tractile EB pattern, a transcriptional module of muscle and
cardiomyocyte developmental-related genes showed higher
expression in Uhrf1 KO EBs at week 1, but dramatically
decreased at week 2 and week 3 as compared to WT EBs
(module 23 in Fig. 2g). Consistent with qPCR results (Fig. 2c), a
gene set related to ectodermal development (neural crest and
neuron development) was down regulated in Uhrf1 KO EBs when
compared with WT (module 26 in Fig. 2g).
To further investigate whether the observed higher mesoder-
mal lineage differentiation and neuroectodermal commitment
defects were related to disruption of bivalent chromatin on
developmental promoters, we performed ChIP-seq against
H3K4me3 and H3K27me3 in both WT and Uhrf1 KO EBs. We
observed a similar pattern to undifferentiated ESCs with respect
to the active or no-mark, as these were largely unchanged in
Uhrf1 KO EBs (Supplementary Fig. 3b). However, both bivalent
and repressive promoters became increasingly disrupted, con-
comitant with EB differentiation. GO analysis showed that the
bivalent disruptions were enriched near promoters of lineage-
specific genes (Fig. 2h). Interestingly, mesodermal and neuroec-
todermal lineage markers displayed different promoter modifica-
tion defect in Uhrf1 KO cells. For example, neuroectodermal
genes (Edrna, Otx2, and Neurod1) displayed a failure to gain of
H3K4me3 marks on their promoter regions during Uhrf1 KO EB
differentiation (FDR < 8.61e−3), while the muscle or heart
developmental genes (Nkx2.5, Tbx5, and Wnt2b) showed a loss
of the H3K27me3 modification on bivalent promoters (Supple-
mentary Fig. 3c). These differential depositions of histone marks
on two distinct lineages may account for the biased differentiation
observed in Uhrf1 KO ESCs.
Uhrf1 regulates the H3K4me3 with Setd1a/COMPASS com-
plex. Next, we asked how Uhrf1 regulates histone modifications
and how the loss of Uhrf1 function leads to disruption of bivalent
histone modifications. First, we investigated if modulation of
Uhrf1 expression levels directly influenced histone modification.
We either overexpressed or depleted Uhrf1 in mouse embryonic
fibroblasts (MEFs) and mESCs, and then we examined H3K4me3,
H3K27me3, and H3K9me3 modifications. We observed large
changes in H3K9me3 and H3K4me3 that are strongly correlated
with the expression levels of Uhrf1 (Supplementary Fig. 4a),
suggesting that Uhrf1 is not only enriched on the bivalent loci,
but also regulates global active histone modification levels.
Uhrf1 does not have a catalytic domain for HMT activity28,
indicating that this euchromatic function of Uhrf1 may be
regulated via interplay with other catalytic enzymes. In order to
identify proteins that interact with Uhrf1 and modulate histone
modification, we analyzed the protein interactome of Uhrf1. To
enable this, we established the J1 ESC lines that expressed sub-
endogenous level of FLAG-tagged and biotinylated Uhrf1
(Supplementary Fig. 4b)29. Multi-protein complexes were purified
using one-step anti-FLAG and streptavidin affinity capture
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combined with mass spectrometry analysis. We identified 159
Uhrf1-interacting proteins, including Dnmt1, which is a well-
known binding partner of Uhrf18 (Supplementary Data 1). GO
analysis determined that many interacting proteins were related
to cell cycle and chromatin structure regulation (Supplementary
Fig. 4c). Comparative analysis of our Uhrf1 interaction data
against the public interactome databases identified that Uhrf1
interacts with PRC2, the Kap1 complex, and Dnmt1. Interest-
ingly, the Setd1a/COMPASS complex proteins that catalyze the
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methylation of histone H3 at lysine 4 were found to interact with
Uhrf1 (Supplementary Fig. 4d).
The way Uhrf1 recognizes and modifies histone H3 at lysine 9
is already well established9–11. H3K27me3 cooperates with
H3K9me3 for heterochromatin formation by maintaining an
abundance of heterochromatin protein 1 alpha (HP1a)30. It also
has been reported that Dnmt1 mediates an interplay between
DNA methylation and H3K27me3 at pericentric heterochroma-
tin, and Uhrf1 KO ESCs can affect the kinetics of H3K27me3
modification through a Dnmt1-dependent DNA methylation
mechanism31. However, to our knowledge, how Uhrf1 regulates
H3K4me3 modification still remains elusive. Therefore, we
focused on identifying the molecular mechanism of H3K4me3
regulation through Uhrf1.
First, we confirmed the interaction of Uhrf1 with Setd1a and its
core complex proteins by co-immunoprecipitation (Co-IP)
(Fig. 3a). Furthermore, to identify the specific domain of Uhrf1
that mediated the Setd1a interaction, a series of domain-specific
mutants were generated, and assessed for binding with Co-IP.
Notably, deletion of the SRA domain abolished the interaction of
Uhrf1 with Setd1a (Fig. 3b). Interestingly the SRA domain alone
was sufficient to interact with Setd1a (Supplementary Fig. 4e). In
addition, the SET domain of Setd1a is critical for interacting with
Uhrf1 (Fig. 3c). To clarify whether Uhrf1–Setd1a interaction is
direct or mediated through other proteins, we performed in vitro
interaction assays with recombinant proteins. We purified
recombinant Uhrf1 and used this as bait for interaction assay.
For Setd1a, we used the recombinant human partial SETD1A-
198H proteins (Amino acid, 1418–end), which contains n-SET
and SET domains and has an identical amino acid sequence to the
murine Setd1a protein in SET domain (Supplementary Fig. 4f).
When we performed in vitro binding assay with these two
recombinant proteins, we clearly demonstrated their direct
interaction (Supplementary Fig. 4g).
From these data, we postulated that Uhrf1’s ability to regulate
H3K4me3 was potentially through its interaction with and
recruitment of the Setd1a/COMPASS complex. To test this, we
performed an in vitro HMT assay22. Uhrf1 complex was
immunoprecipitated from ESCs and used for subsequent HMT
assays. The affinity-purified Uhrf1 complex demonstrated
methyltransferase activity (Fig. 3d), and western blot analysis
further revealed that the Uhrf1 complex-mediated methylation on
lysine 4 of Histone 3 (Fig. 3d). To verify that Setd1a is the major
protein mediating H3K4 methylation in Uhrf1 complex, we
knocked down Setd1a using shRNA in ESCs and then performed
the HMT assay. We found that the depletion of Setd1a
dramatically reduced the H3K4 methylation activity of the Uhrf1
complex, demonstrating that Uhrf1 controls the H3K4 methyla-
tion through its interaction with the Setd1a complex (Fig. 3e).
To further understand the role of Uhrf1 domains in H3K4
methylation, we next tested a series of domain-deleted Uhrf1 for
HMT activity toward H3 substrates. The deletion of the SRA
domain in Uhrf1 abolished its tri-methylation activity of H3K4,
while deletion of the PHD or the TTD domains had no affect on
its HMT activity (Fig. 3f). As shown in the interaction assay, SRA
domain alone that is necessary and sufficient to interact with
Setd1a was sufficient to induce the HMT activity, as well as
H3K4me3 modification (Supplementary Fig. 4h). Interestingly,
when we used assembled chromatin substrates, which includes
DNA and core histones (H3, H4, H2A, and H2B), the deletion of
TTD and PHD affected the total HMT activity, although
H3K4me3 was not abolished as assessed by western blotting
(Supplementary Fig. 4i). This suggests that the PHD and TTD
domains are necessary for Uhrf1’s function on naive chromatin,
including DNA methylation or histone modifications other than
H3K4me3. Overall, our results demonstrate that the SRA domain
alone is essential for mediating H3K4me3 modifications by a
direct interaction with Setd1a.
Uhrf1 is essential for reprogramming by recruiting Oct4. Our
data demonstrate that Uhrf1 plays important roles in lineage
specification of ESCs via faithful maintenance of histone mod-
ifications. Interestingly, we observed a dramatic up-regulation of
Uhrf1 and Setd1a/COMPASS complex genes with reprogram-
ming factors (Fig. 4a and Supplementary Fig. 5a). The expression
levels of Uhrf1 peaked at day 13, when reprogramming is com-
pleted. We thus hypothesized that Uhrf1 is critical in the acqui-
sition of pluripotency. Notably, overexpression of Uhrf1 in MEFs
dramatically increased the reprogramming efficiency with three
reprogramming factors (Oct4, Sox2, Klf4) but not with four
factors (Oct4, Sox2, Klf4, and Myc) (Fig. 4b). Pluripotency of
induced pluripotent stem cells (iPSCs) derived from OSK+Uhrf1
(iOSKU-13) was validated by qPCR, FACS analysis, and IHC
analysis against a battery of ESC markers (Fig. 4c, d and Sup-
plementary Fig. 5b). Furthermore, teratoma assay and chimera
formation supported that iOSKU-13 was indeed pluripotent
(Fig. 4d). We also tested the role of Uhrf1 in reprogramming by
deleting Uhrf1. MEFs were isolated from Uhrf1fl/fl embryos, and
Uhrf1 was subsequently deleted by expression of Cre recombinase
(Supplementary Fig. 5c). Within a week of deletion, Uhrf1 KO
MEFs showed normal proliferation (Fig. 4e), but failed to
undergo proper reprogramming (Fig. 4f). Depletion of Uhrf1 by
shRNA further supported the necessity of Uhrf1 for somatic cell
reprogramming (Supplementary Fig. 5d and Supplementary
Fig. 2 Uhrf1 deficiency induces neural differentiation defects. a In vitro EB formation of WT, Uhrf1 KO, and Uhrf1 KO ESCs expressed with Uhrf1. ESCs were
differentiated for 3 weeks as EBs. Arrows indicate the cystic hollow. The scale bar represents 4 mm. b Appearance of spontaneous contractile activity
during EBs growth. EBs were examined daily under the microscope for the presence of a rhythmic beating until day 21. Data are from n= 3 independent
experiments. c qPCR analysis of lineage- specific markers and pluripotency marker upon in vitro differentiation. Data are expressed relative to WT ESCs
values and values are normalized to β-actin. Data are from n= 3 independent experiments. The data values are mean ± s.d. **P < 0.05 by unpaired, two-
tailed Student’s t-test analysis. d Immunostaining of differentiated EBs. EBs were treated with Trypsin–EDTA at EB week 1 and plated onto gelatin-coated
plates. Immunostaining with lineage-specific markers was performed 2 days after plating. The scale bar represents 4mm. e Teratomas derived from
immune deficiency mice. Scale bar represent 1 cm. f Representative histological sections from teratomas that developed in immunodeficient mice following
injection with WT and Uhrf1 KO ESCs. Haematoxylin and eosin (H&E) staining reveal characteristic tissues from the endoderm, mesoderm, and ectoderm.
The data are represented as n= 6 experimental replicates. The Scale bar represents 4 mm. g Expression pattern of transcriptional modules related to
muscle differentiation and neuronal differentiation. Thick red and blue lines represent average relative gene expression to WT at week 0 in WT and Uhrf1
KO, respectively. Ribbon colors represent SEM. Representative genes and overrepresented GO terms are shown. Asterisk (*) represents significant
difference (>1.25 fold change and Student’s t-test p-value < 0.05) of gene expression between WT and Uhrf1 KO in each module. h Disruption of bivalent
and repressive promoters in developmental genes. Over representation of GO terms in genes with changes from bivalent to active (B–A) and to repressive
(B–R) and from repressive to no mark (R–N) is shown by heat colors
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Fig. 5e). These results imply that Uhrf1 potentially modulates
pluripotent regulatory networks.
Oct4, Sox2, and Nanog are core transcriptional factors
regulating genes associated with pluripotency32. Co-IP experi-
ments revealed a significant interaction of Uhrf1 with Oct4
(Fig. 5a). In addition, Uhrf1 weakly interacted with Sox2, but not
with Nanog. To determine the mechanism how Uhrf1 regulates
pluripotency, we performed ChIP-seq against the core pluripo-
tency transcription factors, Oct4, Sox2, and Nanog, both in WT
and Uhrf1 KO ESCs. Despite a limited change in their expression,
Oct4 binding was dramatically decreased in Uhrf1 KO ESCs,
whereas Sox2 and Nanog binding was increased (Fig. 5b).
Approximately half of WT-specific Oct4-binding sites were
replaced by either Sox2 or Nanog in Uhrf1 KO cells, and the
remainder showed a loss of Oct4 binding without any replace-
ment(Fig. 5c). Specifically, genes involved in stem cell main-
tenance were enriched in regions showing replacement of loss of
Oct4 binding with Sox2 and Nanog (Supplementary Fig. 6a, FDR
= 4.96e−4), suggesting that Sox2 and Nanog compensates for the
dysregulation of Oct4 binding to maintain pluripotency in Uhrf1
KO cells.
To assess the effect of loss of Oct4 binding in Uhrf1 KO cells
on chromatin structure, we performed assay for transposase
accessible chromatin with high-throughput sequencing (ATAC-
seq). Depletion of Uhrf1 significantly decreased chromatin
accessibility in locations where Oct4 binding was lost, but not
in locations replaced with either Sox2 or Nanog (Fig. 5d, and S6B,
p= 1.17e−10). The loci showing loss of Oct4 binding upon Uhrf1
KO were correlated with regions highly enriched with Uhrf1
(Fig. 5e, p < 2.2e−16). We also observed that H3K4me3 was
significantly reduced with loss of Oct4 binding (Fig. 5f, p < 2.2e
−16), indicating that Uhrf1 directly regulates Oct4 binding by
mediating an active open chromatin conformation.
Genes where Oct4 binding was lost but Sox2 or Nanog
replacement was not made included mesodermal, neuroectoder-
mal, and pluripotent genes (Supplementary Fig. 6c). Thus, the
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loss of Oct4 binding potentially influences both development and
pluripotency. The Zscan4 gene cluster, which is specifically
activated in 2-cell (2C) embryos and essential for iPSC formation,
was one of the identified targets of the loss of Oct4 binding
(Fig. 5g)33. Zscan4 family was the most down-regulated genes in
Uhrf1KO ESCs (Fig. 5h). We also identified previously unchar-
acterized genes (Gm8300, BB287469, Gm2022, Gm5662,
Gm21312, Gm21293, and Gm21304) that are activated in the 2C
stage and are included in top 20 down-regulated genes in
Uhrf1KO ESCs (Fig. 5h and Supplementary Figs. 6d). Similarly
with Zscan4, these 2C genes form gene clusters in specific
chromosomal loci (Gm8300-2022 and Gm21312-21304) (Fig. 5h
and Supplementary Fig. 6d). The loss of Oct4 binding was also
observed in the vicinity of these 2C clusters along with active
chromatin conformation changes (Fig. 5g and Supplementary
Fig. 6e, f). Furthermore, a 2C-specific retrotransposon, MERVL,
was also significantly down-regulated with the loss of Oct4
binding (Supplementary Fig. 6g, h). Therefore, 2C genes appear
to be a direct target of Uhrf1 and Uhrf1-mediated Oct4 binding.
Overall, our results indicate that Uhrf1 regulates both embryonic
cell development and somatic cell reprogramming by mediating
chromatin conformation changes and the binding of core
pluripotent factors.
Discussion
Previous studies have shown that Uhrf1 is critical in maintaining
DNA methylation by regulating Dnmt1 and forming hetero-
chromatin as a reader of H3K9me34,24. In this study, we have
identified a novel function of Uhrf1 in ESCs, in the maintenance
of bivalent chromatin structures through the interaction with
the Setd1a/COMPASS complex protein.
Although a number of phenotypes in Uhrf1 KO cells (i.e. cell
death and small teratoma) overlapped with the Dnmt1 KO34,
importantly we observed a number of unique features in this
Uhrf1 KO study. Transcriptome analysis of Dnmt1 and Uhrf1
KO ESCs demonstrated distinct profiles that segregated the two
KO phenotypes with regards to pluripotency and developmental
gene expression. Global histone modification analyses by ChIP-
seq also revealed that the deletion of Uhrf1 induced a significant
disruption in both H3K4me3 and H3K27me3 histone modifica-
tions, mainly on bivalent promoters (Fig. 1). The observed
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bivalent disruption in Uhrf1 KO implicates Uhrf1 in the tran-
scriptional dysregulation of lineage specification markers during
differentiation (Fig. 2). This was further supported during
spontaneous EB differentiation of Uhrf1 KO ESCs, which showed
a higher expression of cardiac developmental genes, but reduced
expression of neuroectodermal genes (Fig. 2). Notably, cardiac
developmental genes displayed loss of H3K27me3, whereas sig-
nificant reduction of H3K4me3 was detected on neuroectodermal
genes.
We demonstrated that the interaction of Uhrf1 with the Setd1a
complex proteins is critical for maintaining promoter bivalence
and neuroectodermal specification in ESCs. Like Uhrf1 KO ESCs,
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Setd1a KO ESCs also present with defects in neuroectodermal
differentiation20. Interestingly, Mll2 KO ESCs showed delayed
cardiomyocyte differentiation rather than neuroectodermal
defect, further supporting that Uhrf1 regulates neuroectodermal
specification with the Setd1a/COMPASS complex35. As stated,
neuroectodermal genes are down-regulated in Uhrf1 KO EBs, but
are upregulated in Dnmt1 KO EBs36. Another key interesting
difference is that Dnmt1 KO cells successfully undergo differ-
entiation to mature astrocytes37. Our data demonstrated that the
disruptions of bivalent marks in Uhrf1 KO are not due to dis-
ruptions in H3K9me3 or Dnmt1, but partly the loss of Setd1a
function, which results in the reduction of H3K4me3 modifica-
tion on neuroectodermal gene promoters.
In contrast to H3K4me3-mediated neuroectodermal lineage
regulation, Uhrf1 KO cells showed a reduction of H3K27me3 on
mesodermal lineage genes. One potential explanation is that the
decrease of H3K27me3 in Uhrf1 KO may be due to the failure to
recruit PRC2 at mesodermal gene promoters. This is further
supported by our proteomics study showing the direct interaction
of Uhrf1 with Rbbp4, which is one of components of PRC2. In
addition, PRC2-deficient ESCs increased expression of meso-
dermal markers38. Because of the accompaniment and crosstalk
of repressive epigenetic modifications30,31, Uhrf1-mediated PRC2
recruitment may be more linked with H3K9me3 and Dnmt1. As
observed in Uhrf1 KO EBs, Dnmt1 KO EBs activate mesodermal
genes earlier than WT39. The detailed molecular mechanisms
underlying skewed mesodermal lineage differentiation in Uhrf1
KO cells still require further investigation.
Regulation of euchromatic genes by Uhrf1 is poorly under-
stood. The Shi lab has demonstrated that Uhrf1 recognized his-
tone H3 unmodified arginine 2 (H3R2) with its PHD domain and
is involved in activating target genes11. In our study we found that
Uhrf1 interacts with Setd1a/COMPASS complex proteins and
directs the catalytic activity of Setd1a for H3K4 methylation. In
addition, the PHD and TTD domains of Uhrf1 are dispensable
for binding Setd1a (Fig. 3b and Supplementary Fig. 4e) and also
methylation of H3 substrate (Fig. 3f). These domains nevertheless
seem essential for the interaction and methylation of naive
chromatin (Supplementary Fig. 4i). It is known that H3R2
methylation antagonizes H3K4 methylation40,41. Thus, binding of
unmodified H3R2 by Uhrf1 could potentially mediate or prime
catalytic modification of H3K4me3 by Setd1a/COMPASS
complex.
The importance of iPSCs in the context of cell therapeutics and
disease modeling has led to consolidated efforts to understand the
molecular basis of reprogramming, including epigenetic reg-
ulators for DNA methylation and histone modification42,43.
Dnmt3a was shown to be dispensable for reprogramming44, but
inhibition of Dnmt1 accelerates reprogramming45. Proteins of the
PcG and TrxG complexes have been tested for their roles in
reprogramming46. Setd1a and Wdr5 are essential for repro-
gramming, while Ezh2, Suz12 and Eed were shown to be dis-
pensable47,48. In this study, we observed a ∼100-fold increase in
reprogramming efficiency of MEFs when Uhrf1 was included
with a three-factor cocktail of Oct4, Sox2, and Klf4 (Fig. 4).
Because members of the Setd1a/COMPASS complex interact with
Uhrf1 (Fig.3a), Uhrf1 may recruit the Setd1a/COMPASS complex
proteins to reprogramming targets, and facilitate the formation of
pluripotency transcriptional networks. Indeed, overexpression of
Uhrf1 in MEFs increased H3K4me3 level, while loss of Uhrf1 in
ESCs interrupted binding of the core pluripotency factors to
active chromatin regions. In addition, Uhrf1 KO disrupted Oct4
binding at 2C-specific genes with disruption of active chromatin
conformation and a concomitant reduction of expression. Since
Setd1a was previously proposed as Oct4 co-activator in plur-
ipotent stem cells, the mediation of H3K4me3 by Uhrf1 may be
an important step for 2C-gene activation48,49. The down reg-
ulation of 2C genes could be due to reduced numbers of 2C-like
cells. The 2C-like state is transient, with a non-2C state observed
under conventional ESC medium49, proposing the existence of
feedback or feed forward regulation. Previously, Zscan4 has been
reported to degrade Uhrf1 for telomere maintenance in ESCs50.
Therefore, the interdependent control of Uhrf1 and Zscan4 is one
of potential mechanisms for the interconversion between 2C-like
and non-2C state. Overall, our work identified Uhrf1 as a key
regulator of differentiation and pluripotency through regulation
of Setd1a/COMPASS-mediated histone modification.
Collectively, the findings presented in this study demonstrated
that Uhrf1 has an essential function in regulating bivalent pro-
moters during reprogramming, pluripotency and differentiation.
Additionally, our studies defined a molecular mechanism for
Uhrf1-mediated bivalent chromatin regulation, in which Uhrf1
directly interacts with the Setd1a/COMPASS complex to mediate
the deposition of H3K4me3 modifications for pluripotency.
Methods
Cell culture. E14 and Uhrf1 KO ES cells were obtained from the Koseki group4
and maintained in mES medium (DMEM supplemented with 15% FBS, 1% non-
essential amino acids, 2 mM glutamine, 100 U/mL penicillin/streptomycin, 0.1 mM
β-mercaptoethanol, and 1000 U/mL ESGRO leukemia inhibitory factor) on 0.1%
gelatin or MEF-coated plates, incubated at 37 °C and passaged every second or
third day. Uhrf1fl/fl mice were purchased from EMMA (B6N-Uhrf1tm1a(EUCOMM)
Wtsi/Ieg). Animals were handled according to protocols approved by the Yale
University Animal Care and Use Community. ESCs were isolated from E3.5
embryos and MEFs were prepared from E13.5 embryos and were cultured in mES
medium and 10% FBS supplied DMEM, respectively. Retrovirus expressing Cre
recombinase from pBABEpuro-Cre vector (#1764, Addgene) was used to generate
the Uhrf1 KO cell lines used in this study.
Generation of Uhrf1 transgenic cell lines. To generate mouse BirA-ESC lines that
stably expressed both FLAG and biotin-tagged Uhrf1, BirA-ESCs were transfected
with Uhrf1 constructs using the Amaxa nucleofector (Lonza) according to the
manufacturer’s protocol. Transfected cells were cultured for 10 days in growth
medium supplemented with puromycin. Drug-resistant clones were subsequently
selected based on Uhrf1 expression.
Reprogramming. Retroviruses containing the reprogramming factors (Oct4, Sox2,
Klf4, and Myc) were generated using HEK293T cells27. Briefly 1 × 105 cells were
plated and transfected the next day with reprograming factors using X-tremeGENE
9 according to manufacturer’s instructions. Two days after transfection, super-
natants were collected and concentrated via ultracentrifuge. The titer of each viral
supernatant was calculated. The virus mixture (MOI= 5 for each factor) was then
applied to 1 × 105 MEFs. One day after virus infection, medium was replaced with
DMEM medium supplemented with 10% FBS. After 3 days, cells were replated
onto plates pre-seeded with irradiated MEFs. The cells were cultured with mESCs
medium throughout the reprogramming. Successfully reprogramed cells were fixed
with 4% formaldehyde in PBS and subsequently stained with the Alkaline Phos-
phatase Kit (Sigma-Aldrich) for analysis of reprogramming efficiency.
In vitro HMT assay. Wild type or mutant Uhrf1 protein complexes were purified
using Uhrf1 antibody or FLAG antibody from mESCs. When preparing chromatin
as substrate, HeLa core histones were assembled into chromatin using the chro-
matin assembly kit according to the manufactures instructions (Active motif). For
each HMT assay reaction, 400 ng of assembled chromatin or histone H3 peptide
were incubated with purified Uhrf1 complex in 20 μl reaction buffer (50 mM
Tris–HCl, pH 8.5, 50 mM KCl, 5 mM MgCl2, 0.1 mM EDTA and 10% glycerol)
supplemented with 100 μM cold (for immunoblotting) or 1 μCi 3H-labeled (for
fluorography) S-adenosylmethionine (SAM). Proteins were resolved by SDS-PAGE
and subjected to immunoblotting (cold SAM) or scintillation recording (3H-labeled
SAM). Relative HMT activity was calculated against IgG-enriched or vector-
enriched lysate.
In vitro Uhrf1 and SETD1A-binding assay. GST-tagged recombinant human
partial SETD1A protein (SETD1A-198H, amino acid 1418–end) was purchased
from Creative BioMart Company (Cat #SETD1A-198H). In order to purify
recombinant Uhrf1, Uhrf1 was cloned into pGEX6p1, and transformed into BL21
(DE3) E. coli for purification51. Purified recombinant GST-Uhrf1 protein was
incubated with SETD1A-1418 protein (0.15 and 0.3 μg) in binding buffer (25 mM
HEPES, 100 mM NaCl, 0.02% Triton X-100, 5% Glycerol, 5% BSA, and 1 mM
DTT). Uhrf1 was pulled down using an Uhrf1 antibody and agarose beads. The
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bound proteins were separated on SDS-PAGE gel and used for the western blotting
against a GST antibody
RT-qPCR. Total RNA was isolated using an RNeasy mini kit (Qiagen), and 1 μg of
RNA was transcribed into cDNA using the iScript cDNA Synthesis Kit (Bio-Rad).
RT-qPCR was performed in triplicate using iQ SYBR Green Supermix (Bio-Rad).
Delta values were normalized with β-actin. Error bars represent mean ± SD of
technical triplicates. All primers are shown in Supplementary Data 2.
Western blotting. Protein extracts for the detection of histone modifications were
obtained by incubating cells of interest in RIPA buffer (25 mM Tris–HCl, pH8.0,
150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40, and proteinase
inhibitor cocktail), followed by sonication. Total protein was separated on a 15%
PAGE gel. For the immunoprecipitation, cells were lysed with GST–IP buffer (50
mM Tri–HCl pH 8.0, 150 mM NaCl, 100 mM KCl, 1%NP-40, 2 mM EDTA, and
proteinase inhibitor cocktail) for 15 min on ice and used for immunoprecipitation.
The information of primary antibodies and dilutions is described in Supplementary
Data 3. Uncropped scans of immunoblots are presented in Supplementary Figures
7, 8. The corresponding figure number and the molecular weight in kDa are
indicated. Dotted boxes highlight the cropped areas presented in the figures.
Immunostaining. Cells were fixed with 4% formaldehyde/PBS fixation solution for
15 min and then washed with PBS three times. After permeablization with 0.1%
Triton X-100/PBS solution, cells were subjected to blocking and then incubated
with primary antibody in a 3% BSA/PBS solution. Alexafluor 488 and 555 were
used for fluorescence detection, and DAPI was used for a counter-staining. All
antibodies used in this study were listed in Supplementary Data 3.
Chromatin immunoprecipitation assay. Approximately 2 × 107 ESCs cells were
cross-linked by the addition of formaldehyde (1% final concentration) for 15 min
on a rotator. The cross-linking process was stopped with 0.125 M glycine for 10
min, followed by three washes in PBS. The cells were resuspended in isotonic buffer
supplemented with 1% NP-40 to isolate the nuclei. The isolated nuclei were then
resuspended in ChIP buffer (20 mM Tris–HCl pH 8.0, 150 mM NaCl, 2 mM
EDTA, and protease inhibitors). Extracts were sonicated using for three runs of 10
cycles of 15 s “ON”, 15 s “OFF” at a high power setting. Cell lysate were centrifuged
at 12,000×g for 10 min at 4 °C. The supernatant was diluted with ChIP dilution
buffer (20 mM Tris–HCl pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton) before
the immunoprecipitation step. H3K4me3 (07-473, Millipore), H3K27me3 (07-499,
Millipore), H3K9me3 (ab8898, abcam), Oct4 (#5677, Cell Signaling Technology),
Sox2 (#23064, Cell Signaling Technology), Nanog (#8785, Cell Signaling Tech-
nology), or Uhrf1 (sc98817, Santa Cruz) antibodies were then incubated overnight
at 4 °C on a rotator. All antibodies used in this study are listed in Supplementary
Data 3. Immunoprecipitated complexes were successively washed with washing
buffer I (2% SDS), washing buffer II (50 mM HEPES pH 7.5, 500 mM NaCl, 0.1%
deoxycholate, 1% Triton X-100, 1 mM EDTA), washing buffer III (10 mM
Tris–HCl pH 8.1, 250 mM LiCl, 0.5% NP-40, 0.5% deoxycholate, 1 mM EDTA),
and TE buffer (10 mM Tris–HCl pH 7.5, 1 mM EDTA). All washes were performed
at room temperature for 8 min on a rotator. SDS elution buffer (50 mM Tris–HCl
pH 8.0, 10 mM EDTA, 1% SDS) was added and incubated at 65 °C overnight in
order to reverse crosslink protein–DNA complexes. After reversing the cross-
linking, DNA was purified using a Purification Kit (Invitrogen) according to the
manufacturer’s instructions. Purified DNA was used for sequencing using an
Illumina Genome HiSeq2000, or for qPCR using primers listed in Supplementary
Data 2.
Mass spectrometry and data analysis. One-step affinity purification with SA or
M2 beads was performed as described52. LC–MS/MS sequencing and peptide
identification were performed by Taplin Biological Mass spectrometry Facility at
Harvard Medical School with five biological replicates. Proteins with less than two
unique peptide sequences and common background proteins were removed from
subsequent analysis. The background protein sets were used from a previously
reported list52. The number of unique peptides in each protein was normalized to
the total number of unique peptides from all sequenced proteins. To identify
candidate interaction partners, we searched our data for proteins that had a two-
fold higher normalized count of unique peptides in our biotinylated Uhrf1 SA or
FLAG pull-down libraries when compared to a control BirA-SA or FLAG pull-
down library in at least one replicate of our Uhrf1 pull-downs.
In vitro differentiation. EB differentiation was initiated by forming hanging drops.
Cells were suspended with EB differentiation medium (IMDM containing with
15% FBS, 200 μg/ml transferrin, 0.05 ng/ml ascorbic acid, 1 mM sodium pyruvate,
100 U/mL penicillin/streptomycin, 2 mM glutamine, and 450 μM mono-
thiolglycerol). Multiple 200 cells/30 μL aliquots were pipetted onto bacterial Petri
dishes that were inverted for 3 days at 37 °C, after which the EBs were flushed with
EB differentiation medium and subsequently cultured as 3D spheroids.
mRNA library preparation for next generation sequencing. mRNA was isolated
from 5 μg total RNA using Dynabeads mRNA DIRECT (Invitrogen) and was
fragmented with RNA fragmentation reagent (Ambion). First strand cDNA
synthesis was done using the SuperScript III First-Strand Synthesis System and 3
μg μl−1 random hexamers (Invitrogen), followed by second strand synthesis with
DNA Polymerase I and RNase H. After purification, a sequencing library was
generated from the double-stranded cDNA by using paired-end adaptors (Illu-
mina) and the NEBNext DNA Sample Prep Reagent Set 1 (NEB). This library was
sequenced using an Illumina Genome HiSeq2000.
ATAC-seq. 50,000 cells were lysed in cold lysis buffer (10 mM Tris–HCl, pH7.4,
10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630)53. After spinning at 500×g for
5 min, the pellet was used for transposition reaction by Nextera® DNA Library Prep
Kit. Following purification by Qiagen EinElute kit, ATAC-seq library was con-
structed and amplified by NEB High Fidelity 2xPCR master mix. Finally, the library
was purified by AxyPrepTM Mag PCR Clean-up kit.
Data processing and analysis of RNA-seq, ChIP-seq, and ATAC-seq. Mouse
genome sequences (version mm9) and the genomic coordinates of RefSeq genes
and the repetitive element RepeatMasker were downloaded from UCSC genome
browser. All RNA-seq reads were mapped into mm9 mouse genome using Tophat
(v1.1.4), Samtools (v0.1.18), and Bowtie (v0.12.7) with default parameters54.
Normalized expression value (reads per kilobase per million mapped reads
(RPKM)) was calculated by Cufflinks (v1.1.0) using RefSeq genes as reference
annotation by “--GTF” option55. Public transcriptome data from Dnmt1 KO ESCs
(SRX695151 and SRX695157) and preimplantation embryos (SRP055882) was
downloaded from the NCBI short read archive (SRA)26,56. Genes with more than a
1.5-fold change during at least one time point were used to identify transcriptional
modules. Euclidean distances were calculated from Log2-transformed RPKM values
between all gene pairs with the dist function and were subsequently used for Ward.
D2 hierarchical clustering via the hclust function in R. Transcriptional modules
were then identified by a 20 height cutoff. GOstats in the Bioconductor package
was used to evaluate the overrepresentation of GO terms. The Benjamini and
Hochberg (BH) method was used for multiple test correction by the p.adjust
function. The enrichment of early developmental genes and stem cell functions was
analyzed by GSEA (v2.1.0) software57. Log2-transformed RPKM values were used
for GSEA with 100 permutations of gene sets, classic enrichment statistic and
signal-to-noise metric. Gene sets for early development and stem cell functions
were obtained from a previous publication27.
ChIP-seq and ATAC-seq reads were mapped to mm9 genome by Bowtie2
(v2.1.0) with options “--local -D 15 -R 3 -N 1 -L 20 -i S,1,0.50 -k 1”. Read count
was normalized as total number of mapped reads. Uhrf1 enriched and depleted
regions were assigned when there was more than two-fold difference between ChIP
and input and less than a 0.05 adjusted p-value within 10k-bp sliding window. The
p-value was estimated by Poisson distribution from the ChIP-seq read counts
compared to the normalized input counts58. For histone modifications, peak
regions were identified by the rseg-diff program in RSEG software (v0.4.8) with
parameters “-i 20 –v –mode 2” and the 50bp-deadzone correction file59. Non-
overlapped peak regions between WT and Uhrf1KO were defined as differentially
modified regions. Promoter configuration was classified by H3K4me3 ChIP-seq
reads within ±2kbp of the TSS and by H3K27me3 within ±5kbp. Combination of
log2(H3K4me3/input) > 1 & FDR<0.05 by Poisson test, and log2(H3K27me3/
input) > 1 & FDR<0.05 by Poisson test were used for classification, as follows.
Active promoter: presence of H3K4me3 and absence of H3K27me3; bivalent:
presence of H3K4me3 and presence of H3K27me3; repressive: absence of
H3K4me3 and presence of H3K27me3; no mark: absence of H3K4me3 and absence
of H3K27me3. The retention rate of promoter types was calculated by comparing
KO to WT at each time point.
Oct4, Nanog, and Sox2 binding sites were identified by MACS peak caller
(v1.4.2) with “-g mm” option. Loss and gain of their binding by Uhrf1 depletion
was evaluated by comparing MACS peaks between WT and Uhrf1-/-. Peaks within
100-bp distance were considered as overlapping. Furthermore, WT-specific Oct4
peaks were compared with KO-specific Sox2 and Nanog peaks. We defined WT-
specific Oct4 peaks overlapped with and without KO-specific Sox2 or Nanog peaks
as “replacement” and “loss”, respectively. For example, “Sox2+Nanog
replacement” means that Oct4 alone peak in WT cells was changed into Sox2
and Nanog peak in KO cells. The closet genes to Oct4 peaks were used as
target genes.
ATAC-seq reads, whose fragment size is lower than mono-nucleosome size
(=150 bp), were used for subsequent analyses. Genomic coverage of ATAC-seq
reads was calculated by genomecov function in Bedtools (v2.25.0). Read count was
normalized by total number of mapped reads. ATAC-seq reads within Oct4 peaks
were also counted. The difference of chromatin organization and histone
modifications between WT and Uhrf1-/- ESCs was evaluated by comparing the
normalized read count of ATAC-seq and ChIP-seq within Oct4 peaks with T test.
All high-throughput sequencing data produced by this study were listed in
Supplementary Data 4. (h) MeDIP-seq (ERP000570) in E14 ESCs were
obtained from SRA25. Reads were mapped to mouse genome by Bowtie2 as
described above.
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Chimera formation. iPSC line (iOSKU-13) derived from MEF cells (B6/DBA2
mouse) by expressing Oct4, Sox2, Klf4, and Uhrf1 were injected into fertilized
CD-1 blastocyst to identify the coat-color chimerism. Injection was performed by
Yale Genome Editing Center. In brief, super-ovulated CD1 female was mated with
CD1 male, and fertilized embryos were isolated. CD1 blastocysts were injected with
iOSKU-13, and transferred to uterus of a foster female. Newborn mice were
analyzed for coat-color chimerism.
Statistical analysis. Data were represented as means ± standard errors. Statistical
significance was determined using Student’s t-test. p < 0.05 was defined as statis-
tically significant.
Data availability. All data generated or analyzed during this study are included in
this article or the Supplementary Information files. RNA-seq, ChIP-seq, and
ATAG-seq (GSE113915) datasets generated in this study have been deposited in
the Gene Expression Omnibus (GEO).
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